Comprehensive Characterization of a Novel Intronic Pseudo-Exon Inserted within an e14/a2 BCR-ABL Rearrangement in a Patient with Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Comprehensive Characterization of a Novel Intronic Pseudo-Exon Inserted within an e14/a2 BCR-ABL Rearrangement in a Patient with Chronic Myeloid Leukemia

Published:2010-07 Issue:4 Volume:12 Page:520-524
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Sorel Nathalie,Mayeur-Rousse Caroline,Deverrière Séverine,Roy Lydia,Brottier-Mancini Elisabeth,Guilhot François,Turhan Ali G.,Chomel Jean Claude

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference19 articles.

1. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

2. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype;Melo;Blood,1996

3. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders;Cross;Leukemia,1994

4. Human Splicing Finder: an online bioinformatics tool to predict splicing signals;Desmet;Nucleic Acids Res,2009

5. SROOGLE: webserver for integrative, user-friendly visualization of splicing signals;Schwartz;Nucleic Acids Res,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease Response Assessment Modalities in Chronic Myeloid Leukemia: Past, Present, and Future;Indian Journal of Medical and Paediatric Oncology;2023-11-27

2. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma;Modern Pathology;2019-06-12

3. Prevalence and outcomes of uncommonBCR-ABL1fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre;British Journal of Haematology;2018-07-05

4. Treatment and molecular monitoring update in chronic myeloid leukemia management;Annales de biologie clinique;2017-03

5. Novel BCR-ABL1 fusion and leukemic mutations of SETBP1, PAX5, and TP53 detected by next generation sequencing in chronic myeloid leukemia;Cancer Biology & Therapy;2016-08-12